NASDAQ: MGNX
Macrogenics Inc Stock Ownership - Who owns Macrogenics?

Insider buying vs selling

Have Macrogenics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Thomas SpitznagelSr VP Technical Ops2026-02-155,520$1.71
$9.44kSell
Ezio BonviniSr VP Research CSO2026-02-156,433$1.71
$11.00kSell
James KarrelsSVP and CFO2026-02-155,790$1.71
$9.90kSell
Jeffrey Stuart PetersSenior VP GC and Secretary2026-02-155,147$1.71
$8.80kSell
Eric Blasius RisserPresident and CEO2026-02-156,433$1.71
$11.00kSell
Beth Ann SmithVP Controller Treasurer2026-02-15423$1.71
$723.33Sell
James KarrelsSVP and CFO2026-02-083,860$1.81
$6.99kSell
Jeffrey Stuart PetersSenior VP GC and Secretary2026-02-083,474$1.81
$6.29kSell
Eric Blasius RisserPresident and CEO2026-02-084,311$1.81
$7.80kSell
Thomas SpitznagelSr VP Technical Ops2026-02-083,186$1.81
$5.77kSell

1 of 2

MGNX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MGNX insiders and whales buy or sell their stock.

MGNX Shareholders

What type of owners hold Macrogenics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Target N. V. Biotech15.62%9,929,963$29.09MInsider
Armistice Capital LLC9.95%6,324,000$18.53MInstitution
Vanguard Group Inc6.65%4,226,941$12.38MInstitution
Renaissance Technologies LLC4.58%2,908,631$8.52MInstitution
Acadian Asset Management LLC3.96%2,518,410$7.38MInstitution
Tpg Group Holdings Sbs Advisors Inc3.48%2,208,762$6.47MInsider
Scott Koenig3.41%2,165,915$6.35MInsider
Alta Biopharma Partners III LP3.17%2,013,509$5.90MInsider
Millennium Management LLC3.11%1,974,480$5.79MInstitution
Interwest Partners VIII LP3.00%1,908,716$5.59MInsider

1 of 3

MGNX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MGNX62.39%37.61%Net BuyingNet Selling
ELTX11.31%62.00%Net Buying
ARCT83.37%12.98%Net Buying
PRLD45.19%52.26%Net Selling
CNTB15.14%22.49%

Macrogenics Stock Ownership FAQ

Who owns Macrogenics?

Macrogenics (NASDAQ: MGNX) is owned by 62.75% institutional shareholders, 37.83% Macrogenics insiders, and 0.00% retail investors. Target N. V. Biotech is the largest individual Macrogenics shareholder, owning 9.93M shares representing 15.62% of the company. Target N. V. Biotech's Macrogenics shares are currently valued at $29.09M.

If you're new to stock investing, here's how to buy Macrogenics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.